135 related articles for article (PubMed ID: 14532990)
1. Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
Wisman GB; Hollema H; Helder MN; Knol AJ; Van der Meer GT; Krans M; De Jong S; De Vries EG; Van der Zee AG
Int J Oncol; 2003 Nov; 23(5):1451-9. PubMed ID: 14532990
[TBL] [Abstract][Full Text] [Related]
2. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
3. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
[TBL] [Abstract][Full Text] [Related]
4. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
[TBL] [Abstract][Full Text] [Related]
6. hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression.
Kirkpatrick KL; Ogunkolade W; Elkak AE; Bustin S; Jenkins P; Ghilchick M; Newbold RF; Mokbel K
Breast Cancer Res Treat; 2003 Feb; 77(3):277-84. PubMed ID: 12602927
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of c-myc fails to overcome downregulation of telomerase activity induced by herbimycin A, but ectopic hTERT expression overcomes it.
Akiyama M; Yamada O; Akita S; Urashima M; Horiguchi-Yamada J; Ohno T; Mizoguchi H; Eto Y; Yamada H
Leukemia; 2000 Jul; 14(7):1260-5. PubMed ID: 10914551
[TBL] [Abstract][Full Text] [Related]
9. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
Dong Y; Li T; Liang Y; Zou WZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
[TBL] [Abstract][Full Text] [Related]
12. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
[TBL] [Abstract][Full Text] [Related]
13. Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
Wisman GB; Knol AJ; Helder MN; Krans M; de Vries EG; Hollema H; de Jong S; van der Zee AG
Int J Cancer; 2001 Mar; 91(5):658-64. PubMed ID: 11267977
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
16. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
17. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
18. Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
Wang X; Zhou P; Sun X; Zheng J; Wei G; Zhang L; Wang H; Yao J; Lu S; Jia P
Oncol Rep; 2015 Jun; 33(6):3038-44. PubMed ID: 25873431
[TBL] [Abstract][Full Text] [Related]
19. Telomerase and c-myc expression in hepatocellular carcinomas.
Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
